AUSTIN, Texas, July 19, 2012 /PRNewswire/ -- Vermillion, Inc. (NASDAQ: VRML), a leading molecular diagnostics company, will hold a conference call on Tuesday, August 14, 2012 at 4:30 p.m. Eastern time to discuss results for the second quarter ended June 30, 2012. Financial results will be issued in a press release prior to the call.
Vermillion management will host the call, followed by a question and answer period.
Date: Tuesday, August 14, 2012
Time: 4:30 p.m. Eastern time (1:30 p.m. Pacific time)
Dial-In Number: 1-800-705-6212
Conference ID#: 21599716
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Liolios Group at 1-949-574-3860.
A replay of the call will be available approximately two hours after the call and until August 28, 2012.
Toll-free replay number: 1-800-633-8284
International replay number: 1-402-977-9140
Replay pin number: 21599716
Vermillion, Inc. (NASDAQ: VRML) is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, cardiology and women's health. Additional information about Vermillion can be found at www.vermillion.com.
Investor Relations: Liolios Group, Inc. Ron Both Tel 949-574-3860 VRML@liolios.com
SOURCE Vermillion, Inc.